Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14GILEAD SCIENCES INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

LEDIPASVIR; SOFOSBUVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205834

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

LEDIPASVIR; SOFOSBUVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212477

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR; VELPATASVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214187

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209195

Patent Use Code : U-2039

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-21

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR; VELPATASVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208341

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209195

Patent Use Code : U-2040

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-03-21

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212480

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204671

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR; VELPATASVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214187

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

SOFOSBUVIR

US Patent Number : 8334270

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212480

Patent Use Code : U-1470

Delist Requested :

Patent Use Description : FOR THE TREATMENT OF H...

Patent Expiration Date : 2028-03-21

blank